Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
29 /100
MEDIUM RISK
Score updated Oct 13, 2026

STAA — STAAR Surgical Company Dilution Risk Tracker

Track STAA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track STAA — Get alerts when the score changes →

As of October 13, 2026, STAAR Surgical Company (STAA) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. STAAR Surgical Company has a market capitalization of $1.10B, 50.14M shares outstanding, 192 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for STAA.
🔔 Track STAA — Get forecast alerts →

Market Data

Market Cap$1.10B
Shares Outstanding50.14M
Float24.56M
Cash$181.49M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore29/100DilutionWatch score record
Shares Outstanding50.14MVerified float table or market cache
Public Float24.56MVerified float table or market cache
Market Cap$1.10BMarket data cache
Cash Runway200.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 12.5% shares (2026Q1 vs prior)
192 institutional holders · 61.42M shares
#1 BROADWOOD CAPITAL INC 16.12M shares
#2 BlackRock, Inc. 6.67M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.38M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.74M
Days to Cover2.8
% of Float15.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-13
4 INSIDER TRANSACTION 2026-03-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual STAA Dilution Snapshot

STAAR Surgical Company (STAA) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

STAA's DilutionScore is currently 29/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 30/100 (Medium risk).

Period Score Risk Level Duration
Sep 16 – Oct 13, 202629/100MEDIUM28 days
Jul 16 – Sep 15, 202630/100MEDIUM61 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

STAA shares outstanding have increased 0.9% from 49.37M (Mar 2026) to 49.79M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202649.79M24.56M▼ 0.15%
May 22, 202649.79M24.60M▼ 9.59%
May 17, 202649.79M27.21M▲ 0.46%
May 16, 202649.79M27.08M▲ 258.62%
May 12, 202649.79M7.55M▼ 71.97%
Apr 24, 202649.51M26.94M▼ 9.58%
Mar 28, 202649.51M29.79M▼ 0.18%
Mar 17, 202649.51M29.85M▼ 2.20%
Mar 07, 202649.37M30.52M▼ 0.28%
Mar 05, 202649.37M30.61M▼ 0.46%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track STAA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment STAA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking STAA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Med Devices sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for STAA
STAA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.